Skip to main content

Advertisement

SpringerLink
Log in

The power of the placebo

  • Published:
Current Allergy and Asthma Reports Aims and scope Submit manuscript

Abstract

The placebo is much more than a control medicine in a clinical trial. The placebo response is the largest component of any allergy treatment and consists of two components: nonspecific effects (eg, natural recovery) and a “true placebo effect” that is the psychological therapeutic effect of the treatment. Belief in the beneficial nature of the treatment is a key component of the true placebo effect, and can be enhanced by factors such as interaction with the physician and the sensory impact of the treatment. Negative beliefs can generate a nocebo effect that may explain some psychogenic illnesses; this is the basis of much research in psychoneuroimmunology. An understanding of the placebo and nocebo effects is important for general allergy practice, and harnessing the power of the true placebo effect is a major challenge to modern medicine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Benson H, Friedman R: Harnessing the power of the placebo effect and renaming it “remembered wellness.” Annu Rev Med 1996, 47:193–199.

    Article  PubMed  CAS  Google Scholar 

  2. Harrington A, ed: The Placebo Effect: An Interdisciplinary Approach. Cambridge, MA: Harvard University Press; 1999.

    Google Scholar 

  3. Guess H, Kleinman A, Kusek J, Engel L, eds: The Science of the Placebo: Towards an Interdisciplinary Approach. London: BMJ Books; 2002.

    Google Scholar 

  4. Moerman D: Meaning, Medicine and the “Placebo Effect.” Cambridge: Cambridge University Press; 2002.

    Google Scholar 

  5. Evans D: Placebo: The Belief Effect. London: Harper Collins; 2003.

    Google Scholar 

  6. Shure N: The placebo in allergy. Ann Allergy 1965, 23:368–376.

    PubMed  CAS  Google Scholar 

  7. Glover MT, Atherton DJ: A double-blind controlled trial of hyposensitization to Dermatophagoides pteronyssinus in children with atopic eczema. Clin Exper Allergy 1992, 22:440–6.

    Article  CAS  Google Scholar 

  8. Van Cauwenberge P, Juniper EF: Comparison of the efficacy, safety, and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg, and placebo administered once daily for the treatment of seasonal allergic rhinitis. Clin Exper Allergy 2000, 30:891–899.

    Article  Google Scholar 

  9. Juniper EF, Guyatt GH, Griffith LE, Ferrie PJ: Interpretation of rhinoconjunctivitis quality of life questionnaire data. J Allergy Clin Immunol 1996, 98:843–845.

    Article  PubMed  CAS  Google Scholar 

  10. Ernst E, Resch KL: Concept of true and perceived placebo effects. BMJ 1995, 311:551–553.

    PubMed  CAS  Google Scholar 

  11. Eccles R: Placebo effects of antitussive treatments on cough associated with acute upper respiratory tract infection. In Cough, Causes, Mechanisms and Therapy. Chung KF, Widdicombe JG, Boushey HA, eds. Malden, MA: Blackwell Publishing; 2003:259–268.

    Google Scholar 

  12. Kienle G, Kiene H: Placebo effect and placebo concept: a critical methodological and conceptual analysis of reports on the magnitude of the placebo effect. Alternative Therapies 1996, 2:39–54.

    CAS  Google Scholar 

  13. Lee PC, Jawad MS, Hull JD, et al.: The antitussive effect of placebo treatment on cough associated with acute upper respiratory infection. Psychosom Med 2005, 67:314–317.

    Article  PubMed  Google Scholar 

  14. Eccles R: Mechanisms of the placebo effect of sweet cough syrups. Respir Physiol Neurobiol. 2006, 152:340–348.

    PubMed  Google Scholar 

  15. Song C, Leonard BE: Fundamentals of Psychoneuroimmunology. Chichester, England: John Wiley and Sons; 2000.

    Google Scholar 

  16. Fleshner M, Laudenslager ML: Psychoneuroimmunology: then and now. Behav Cogn Neurosci Rev 2004, 3:114–130.

    Article  PubMed  Google Scholar 

  17. Blackwell B, Bloomfield SS, Buncher CR: Demonstration to medical students of placebo responses and non-drug factors. Lancet 1972, 1:1279–1282.

    Article  PubMed  CAS  Google Scholar 

  18. Hahn R: The nocebo phenomenon: scope and foundations. In: Harrington A, ed. The Placebo Effect: An Interdisciplinary Approach. Cambridge, MA: Harvard University Press; 1999:56–76.

    Google Scholar 

  19. Luparello T, Lyons HA, Bleecker ER, McFadden ER, Jr: Influences of suggestion on airway reactivity in asthmatic subjects. Psychosom Med 1968, 30:819–825.

    PubMed  CAS  Google Scholar 

  20. World Medical Association: Declaration of Helsinki. Available at: http://www.wma.net/e/policy/b3.htm.

Download references

Author information

Authors and Affiliations

  1. Common Cold Centre, Cardiff School of Biosciences, Cardiff University, Cardiff, CF10 3US, UK

    Ron Eccles BSc, PhD, DSc

Authors
  1. Ron Eccles BSc, PhD, DSc
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ron Eccles BSc, PhD, DSc.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eccles, R. The power of the placebo. Curr Allergy Asthma Rep 7, 100–104 (2007). https://doi.org/10.1007/s11882-007-0006-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11882-007-0006-2

Keywords

Search

Navigation